Skip to main content

Christopher B. Atzinger, MS, PhD candidate

Authored Items
Biologic Disease-Modifying Antirheumatic Drugs in a National, Privately Insured Population: Utilization, Expenditures, and Price Trends
Christopher B. Atzinger, MS, PhD candidate, Byron C. Scott, MD, MBA, Jeff J. Guo, BPharm, PhD
February 2017 Vol 10, No 1 in Practice Management
Last modified: April 23, 2019